Explore more publications!

Press Releases

This is how Epstein is linked to Israel

This is how Epstein is linked to Israel

Silynxcom Receives Over $286,000 Tactical Communication Headset Order from the Israel Defense Forces
Ellomay Capital Provides Updates on its Italian Solar Operations
Clearmind Medicine Kicks-Off Patient Enrollment at Tel Aviv Sourasky Medical Center, Adding Another Site Activated in its in Phase I/IIa Alcohol Use Disorder Trial
EU Commissioner Says Israel Blocked Her from Entering Gaza

EU Commissioner Says Israel Blocked Her from Entering Gaza

Econergy secures €40.5M project financing for its 87 MW Oradea solar project in Romania
The Global Data Center Power Market to Reach USD 75.24 Billion by 2030 | Market Size, Share, and Trends – Arizton
Hamas condemns abuse of Palestinian prisoners in Israeli jails

Hamas condemns abuse of Palestinian prisoners in Israeli jails

Knesset cancels Jordanian with new law letting Israelis own property

Knesset cancels Jordanian with new law letting Israelis own property

Cal-Maine Foods Positions for Growth in Prepared Foods with New Leadership and Expansion Plans
France voices deep concern of Israeli attacks on Lebanon

France voices deep concern of Israeli attacks on Lebanon

New Survey Reveals High-Tech Employees Use AI as Part of Workflow, Driving Major Productivity Across Israeli Tech Sector
Israel Launches Next Phase of National Drone Initiative, Paving the Way for Drone-Based Commercial Aerial Services
Polyrizon Reports Positive Mucoadhesion Results for Intranasal Naloxone Hydrogel Compared to Marketed Intranasal Naloxone product
Turkey calls on UN members to support Palestine resolution

Turkey calls on UN members to support Palestine resolution

Pope Leo XIV Urges Europe to Confront Roots of Islamophobia

Pope Leo XIV Urges Europe to Confront Roots of Islamophobia

Fortuna Awards the Séguéla Mine Plant Expansion Study, Côte d’Ivoire
PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission
PainReform Commences Development for OcuRing™-K Phase II Trial, LayerBio’s Drop-Less Sustained-Release Ocular Therapy
Gauzy Ltd. Raises $12 Million Investment to Advance Capital Objectives and Provides Update on Board Composition

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions